| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $58M |
Buys | $0 | 0 | 0 |
Sells | $1,661,597 | 18 | 100 |
| GAROFALO ELIZABETH A. | director | 0 | $0 | 1 | $89,673 | $-89,673 |
| Kihara James | PRINCIPAL ACCOUNTING OFFICER | 0 | $0 | 6 | $221,227 | $-221,227 |
| Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 0 | $0 | 2 | $319,310 | $-319,310 |
| DAVIS STEPHEN | CEO | 0 | $0 | 1 | $485,094 | $-485,094 |
| Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 0 | $0 | 8 | $546,292 | $-546,292 |
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Over the last 12 months, insiders at ACADIA Pharmaceuticals Inc. have bought $0 and sold $1.66M worth of ACADIA Pharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at ACADIA Pharmaceuticals Inc. have bought $30.16M and sold $5.33M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 294,154 shares for transaction amount of $7.45M was made by BAKER BROS. ADVISORS LP () on 2023‑05‑24.
| 2025-05-16 | Sale | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2,000 0.0013% | $25.00 | $50,000 | -8.57% | |
| 2025-05-16 | Sale | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 4,000 0.0024% | $22.50 | $90,000 | -8.57% | |
| 2025-05-02 | Sale | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 3,498 0.002% | $14.60 | $51,071 | +17.75% | |
| 2025-05-02 | Sale | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 1,327 0.0008% | $14.60 | $19,374 | +17.75% | |
| 2025-04-08 | Sale | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 2,708 0.0016% | $14.82 | $40,133 | +5.28% | |
| 2025-04-08 | Sale | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 1,028 0.0006% | $14.82 | $15,235 | +5.28% | |
| 2025-03-26 | Sale | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 3,171 0.0019% | $17.05 | $54,066 | -12.15% | |
| 2025-03-26 | Sale | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 1,095 0.0007% | $17.05 | $18,670 | -12.15% | |
| 2025-03-05 | Sale | GAROFALO ELIZABETH A. | director | 4,919 0.003% | $18.23 | $89,673 | -7.77% | |
| 2025-02-24 | Sale | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 773 0.0005% | $19.96 | $15,429 | -13.81% | |
| 2025-02-24 | Sale | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 475 0.0003% | $19.96 | $9,481 | -13.81% | |
| 2024-11-19 | Sale | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 10,329 0.0065% | $16.81 | $173,630 | +6.48% | |
| 2024-11-19 | Sale | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 10,259 0.0064% | $16.81 | $172,454 | +6.48% | |
| 2024-11-19 | Sale | Kihara James | PRINCIPAL ACCOUNTING OFFICER | 4,073 0.0025% | $16.81 | $68,467 | +6.48% | |
| 2024-08-19 | Sale | DAVIS STEPHEN | CEO | 31,747 0.0186% | $15.28 | $485,094 | +6.03% | |
| 2024-08-19 | Sale | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 9,534 0.0056% | $15.28 | $145,680 | +6.03% | |
| 2024-08-19 | Sale | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 9,733 0.0057% | $15.28 | $148,720 | +6.03% | |
| 2024-06-10 | Sale | Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 975 0.0006% | $14.79 | $14,420 | +11.69% | |
| 2024-05-02 | Sale | DAVIS STEPHEN | CEO | 11,427 0.0069% | $16.94 | $193,573 | -4.45% | |
| 2024-05-02 | Sale | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 3,477 0.0021% | $16.94 | $58,900 | -4.45% |
| DAVIS STEPHEN | CEO | 186555 0.1115% | $4.08M | 0 | 30 | |
| Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 62105 0.0371% | $1.36M | 0 | 16 | |
| Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 62130 0.0371% | $1.36M | 0 | 20 | |
| Kihara James | PRINCIPAL ACCOUNTING OFFICER | 20395 0.0122% | $445,630.75 | 0 | 19 | |
| GAROFALO ELIZABETH A. | director | 17595 0.0105% | $384,450.75 | 0 | 1 | |
| BAKER BROS. ADVISORS LP | 39058564 23.3378% | $853.43M | 16 | 0 | +14.48% | |
| 14159, L.P. | 20278008 12.1163% | $443.07M | 1 | 0 | +3.15% | |
| BAKER FELIX | 18001203 10.7558% | $393.33M | 4 | 0 | +58.48% | |
| OXFORD BIOSCIENCE PARTNERS IV LP | 10 percent owner | 3160238 1.8883% | $69.05M | 2 | 0 | +29.7% |
| WALTON ALAN G | 2573836 1.5379% | $56.24M | 1 | 0 | +11.11% | |
| van Osch Martien | director | 1168892 0.6984% | $25.54M | 2 | 0 | +29.7% |
| GORDON CARL L | director | 774006 0.4625% | $16.91M | 2 | 0 | +29.7% |
| Brann Mark R | President & CSO | 317756 0.1899% | $6.94M | 0 | 9 | |
| Hacksell Uli | CEO | 115549 0.069% | $2.52M | 1 | 22 | +11.11% |
| Baity Glenn | EVP AND GC | 83734 0.05% | $1.83M | 0 | 25 | |
| Stankovic Srdjan R. | President | 61234 0.0366% | $1.34M | 0 | 23 | |
| KIM AUSTIN D. | EVP,General Counsel, Secretary | 46901 0.028% | $1.02M | 0 | 15 | |
| Iversen Leslie L | director | 36127 0.0216% | $789,374.95 | 1 | 4 | |
| Mills Roger | EVP, DEVELOPMENT AND CMO | 18550 0.0111% | $405,317.50 | 0 | 3 | |
| Brege Laura | director | 13502 0.0081% | $295,018.70 | 0 | 12 | |
| Ridloff Elena | EVP and CFO | 10553 0.0063% | $230,583.05 | 0 | 6 | |
| SOLAND DANIEL B | director | 10000 0.006% | $218,500.00 | 2 | 0 | <0.0001% |
| KAPLAN LESTER J PH D | director | 8500 0.0051% | $185,725.00 | 0 | 3 | |
| Rasmussen Torsten | director | 8500 0.0051% | $185,725.00 | 0 | 6 | |
| YANG MICHAEL J. | EVP and CCO | 8059 0.0048% | $176,089.15 | 0 | 7 | |
| Moore Terrence O | EVP, CHIEF COMMERCIAL OFFICER | 1671 0.001% | $36,511.35 | 0 | 4 | |
| HARRIGAN EDMUND | director | 1000 0.0006% | $21,850.00 | 1 | 0 | <0.0001% |
| Miller Eric Alejandro | Controller & PAO | 270 0.0002% | $5,899.50 | 0 | 3 | |
| BORER MICHAEL T | director | 0 0% | $0 | 0 | 2 | |
| GRAY MARY ANN | director | 0 0% | $0 | 0 | 3 | |
| Aasen Thomas H | EXEC VP, CFO AND CBO | 0 0% | $0 | 0 | 15 | |
| Lundstrom Brian | Sr. VP, Bus. Devt. | 0 0% | $0 | 0 | 5 | |
| Wells William McDowall | director | 0 0% | $0 | 0 | 4 | |
| Daly James M | director | 0 0% | $0 | 0 | 2 |
$11,588,217 | 69 | 42.07% | $2.97B | |
$42,463,802 | 57 | 17.85% | $3.94B | |
ACADIA Pharmaceuticals Inc. (ACAD) | $1,275,975,557 | 32 | 19.44% | $3.66B |
$62,927,079 | 29 | 14.02% | $3.69B | |
$11,859,102 | 17 | 18.62% | $3.74B | |
$103,944,213 | 17 | 5.95% | $3.97B | |
$128,181,928 | 16 | 18.84% | $2.99B | |
$74,605,681 | 14 | 47.06% | $3.19B | |
$177,517,505 | 13 | 16.65% | $3.85B | |
$57,686,748 | 13 | 21.11% | $3.66B | |
$70,151,579 | 12 | 22.57% | $2.92B | |
$11,898,979 | 10 | 54.58% | $3.66B | |
$35,908,794 | 10 | 126.31% | $2.84B | |
$1,711,150 | 9 | 31.59% | $3.06B | |
$4,623,072 | 7 | 11.07% | $3.35B | |
$182,500,000 | 6 | 29.00% | $3.61B | |
$14,400,000 | 5 | 41.34% | $3.48B | |
$41,376,000 | 4 | -12.07% | $4.38B | |
$36,900,000 | 3 | -9.12% | $3.69B |
| Increased Positions | 164 | +46.72% | 30M | +18.18% |
| Decreased Positions | 149 | -42.45% | 19M | -11.61% |
| New Positions | 65 | New | 7M | New |
| Sold Out Positions | 45 | Sold Out | 3M | Sold Out |
| Total Postitions | 366 | +4.27% | 174M | +6.57% |
| Baker Bros. Advisors Lp | $639,310.00 | 25.68% | 42.88M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $318,575.00 | 12.79% | 21.37M | +9M | +67.85% | 2025-03-31 |
| Vanguard Group Inc | $207,959.00 | 8.35% | 13.95M | +104,444 | +0.75% | 2024-12-31 |
| Rtw Investments, Lp | $129,799.00 | 5.21% | 8.71M | -5M | -36.49% | 2024-12-31 |
| Morgan Stanley | $108,799.00 | 4.37% | 7.3M | +6M | +335.42% | 2024-12-31 |
| State Street Corp | $67,414.00 | 2.71% | 4.52M | -1M | -24.31% | 2024-12-31 |
| Assenagon Asset Management S.A. | $54,617.00 | 2.19% | 3.66M | +4M | New | 2025-03-31 |
| D. E. Shaw & Co., Inc. | $48,329.00 | 1.94% | 3.24M | -263,551 | -7.52% | 2024-12-31 |
| Goldman Sachs Group Inc | $42,948.00 | 1.73% | 2.88M | +1M | +63.77% | 2024-12-31 |
| Geode Capital Management, Llc | $42,898.00 | 1.72% | 2.88M | +1,569 | +0.06% | 2024-12-31 |